AR010769A1 - Metodo para la reduccion del crecimiento capilar en mamiferos - Google Patents

Metodo para la reduccion del crecimiento capilar en mamiferos

Info

Publication number
AR010769A1
AR010769A1 ARP970105856A ARP970105856A AR010769A1 AR 010769 A1 AR010769 A1 AR 010769A1 AR P970105856 A ARP970105856 A AR P970105856A AR P970105856 A ARP970105856 A AR P970105856A AR 010769 A1 AR010769 A1 AR 010769A1
Authority
AR
Argentina
Prior art keywords
growth
acid
hydroxy
inhibitor
mmp
Prior art date
Application number
ARP970105856A
Other languages
English (en)
Original Assignee
Gillette Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gillette Co filed Critical Gillette Co
Publication of AR010769A1 publication Critical patent/AR010769A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A61Q7/02—Preparations for inhibiting or slowing hair growth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/347—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A61K8/466—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfonic acid derivatives; Salts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4986—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with sulfur as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/606—Nucleosides; Nucleotides; Nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782—Enzyme inhibitors; Enzyme antagonists

Abstract

Método para reducir el crecimiento del pelo en mamíferos (incluído el ser humano) en particular el crecimiento estimulado por el androgeno, a través dela aplicacion sobre la piel de un compuesto que contiene un inhibidor de una metaloproteinasade la matriz (MMP) en cantidad suficiente para reducir dichocrecimiento. El crecimiento capilar que se inhibe puede ser el crecimiento normal, o crecimiento relacionado con una condicion anormal o enfermedad.Ejemplo de inhibidores de una MMP son: 1,10-fenantrolina (o -fenantrolina); batamistato, también conocido como BB-94, compuestos basados en [4-(N-hidroxiamino)-2R-isobutil-38-(tiopen-2-iltiomatil)-succinil]-L-fenilalanina- N-metilamidacarboxialquilamino tales como N-[1-(R)-carboxi-3-(1,3-dihidro-2H-benz[f]isoindol-2-il)propilo]-N, N-dimetil-L-leucinamida, trifluoroacetato marimastato (BB-3516); M-clorotaurina; ácido sicosapentaenoico; matlistatin-B;actinonina (ácido 3-[[1-[2-(hidroximetil)-1-pirolidinil]-carbamoil]--octanohidroxámico]; N-fosfonalquil dipeptidos tales como N-[N-((R)-1--fosfonopropil)-S-leucil]-S-fenilalanina-N-metilamida; ácidos peptidil hidroxámicos tales como pNH2-Bz-Gli-Pro-D-Leu-D-Ala-NHOH; Ro-31-7467, tambiénconocido como 2-[(5-bromo-2,3-di hidro-6-hidroxi-1,3-dioxo1Hbenz[des] isoquinolin-2-il)metil](hidroxi)-[fosfinil]-N-(2-oxo-3-azaciclotridecanil)-4--metilvaleramida; CT 1166 también conocido como N1(N-[2- (morfolinosulfonilamino)- etil]-3-ciclohexil-2-(8)propanamidil)-N4-hidroxi-2-(R)-[3-(4-metilfenil)propil]succinamida; monofosfato bromocíclico-adenosina; aldehído protocatechuic (3,4-dihidroxibenzal-dehído); estramustina(estradiol-3--bis(2-cloroetil)carbamato). Preferentementeel inhibidor de una MMP incluye un inhibidor distinto del ácido graso insaturado tal como el ácido
ARP970105856A 1996-12-13 1997-12-12 Metodo para la reduccion del crecimiento capilar en mamiferos AR010769A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US76498096A 1996-12-13 1996-12-13

Publications (1)

Publication Number Publication Date
AR010769A1 true AR010769A1 (es) 2000-07-12

Family

ID=25072328

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP970105856A AR010769A1 (es) 1996-12-13 1997-12-12 Metodo para la reduccion del crecimiento capilar en mamiferos

Country Status (11)

Country Link
US (1) US5962466A (es)
EP (1) EP1083863B1 (es)
AR (1) AR010769A1 (es)
AT (1) ATE248573T1 (es)
AU (2) AU5520998A (es)
BR (1) BR9815884B1 (es)
CA (1) CA2333401C (es)
DE (1) DE69817883T2 (es)
ES (1) ES2205498T3 (es)
WO (2) WO1998025580A1 (es)
ZA (1) ZA9711121B (es)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3973748B2 (ja) * 1998-01-14 2007-09-12 花王株式会社 発毛抑制剤
JPH11279040A (ja) * 1998-03-27 1999-10-12 Kao Corp 皮膚外用剤
GB9810464D0 (en) * 1998-05-16 1998-07-15 British Biotech Pharm Hydroxamic acid derivatives
CN1367678A (zh) * 1998-09-30 2002-09-04 宝洁公司 使用酮酰胺治疗脱发的方法
JP2002525305A (ja) * 1998-09-30 2002-08-13 ザ、プロクター、エンド、ギャンブル、カンパニー スルホンアミドを用いた脱毛治療の方法
US6307049B1 (en) 1998-09-30 2001-10-23 The Procter & Gamble Co. Heterocyclic 2-substituted ketoamides
US6300341B1 (en) 1998-09-30 2001-10-09 The Procter & Gamble Co. 2-substituted heterocyclic sulfonamides
US6375948B1 (en) 1999-07-12 2002-04-23 Kao Corporation Treating method for suppressing hair growth
US6235737B1 (en) 2000-01-25 2001-05-22 Peter Styczynski Reduction of hair growth
US6299865B1 (en) 2000-05-02 2001-10-09 Peter Styczynski Reduction of hair growth
US7439271B2 (en) 2001-06-27 2008-10-21 The Gillette Company Reduction of hair growth
AU2002322360A1 (en) * 2001-06-28 2003-03-03 Mount Sinai School Of Medicine Of New York University Methods for diagnosing and treating a disease mediated by decreased mmp-2 function
JP4759182B2 (ja) * 2001-08-03 2011-08-31 花王株式会社 水溶性ショウキョウエキス
US6743822B2 (en) 2001-08-10 2004-06-01 The Gillette Company Reduction of hair growth
US7261878B2 (en) * 2001-08-10 2007-08-28 The Gillette Company Reduction of hair growth
US20030036561A1 (en) * 2001-08-10 2003-02-20 Peter Styczynski Reduction of hair growth
US20040198821A1 (en) * 2002-01-29 2004-10-07 Hwang Cheng Shine Reduction of hair growth
US7160921B2 (en) * 2002-01-29 2007-01-09 The Gillette Company Reduction of hair growth
US20030199584A1 (en) * 2002-04-11 2003-10-23 Ahluwalia Gurpreet S. Reduction of hair growth
DE60331367D1 (de) 2002-12-30 2010-04-01 Angiotech Int Ag Wirkstofffreisetzung von schnell gelierender polymerzusammensetzung
US20040141935A1 (en) * 2003-01-21 2004-07-22 Peter Styczynski Reduction of hair growth
US7015349B2 (en) * 2003-03-26 2006-03-21 The Gillette Company Reduction of hair growth
US20050112075A1 (en) * 2003-11-25 2005-05-26 Hwang Cheng S. Reduction of hair growth
US7722901B2 (en) 2004-01-16 2010-05-25 Cognis Ip Management Gmbh Uses for the extract of a plant of the family Asclepiadaceae
US20050249685A1 (en) * 2004-04-27 2005-11-10 Natalia Botchkareva Reduction of hair growth
AU2005319290A1 (en) * 2004-12-22 2006-06-29 The Gillette Company Reduction of hair growth
KR20070086431A (ko) * 2004-12-22 2007-08-27 더 지렛트 캄파니 서비빈 저해제를 이용한 모발 성장 감소
US7618956B2 (en) * 2005-05-31 2009-11-17 The Gillette Company Reduction of hair growth
US20070059264A1 (en) * 2005-09-13 2007-03-15 Ahluwalia Gurpreet S Reduction of hair growth
US7727516B2 (en) * 2006-02-28 2010-06-01 The Procter & Gamble Company Reduction of hair growth
US9763984B2 (en) 2012-12-21 2017-09-19 Astellas Institute For Regenerative Medicine Methods for production of platelets from pluripotent stem cells and compositions thereof
WO2016172386A1 (en) * 2015-04-21 2016-10-27 The Regents Of The University Of California Enzyme-responsive nanoparticles
US10702544B2 (en) 2016-01-12 2020-07-07 National University Corporation Tokyo Medical And Dental University Composition for ameliorating loss of hair and graying of hair, and use thereof
WO2017212271A1 (en) 2016-06-09 2017-12-14 Johnson Matthey Public Limited Company Electrolytic production of organic chloramine solutions

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3426137A (en) * 1965-12-23 1969-02-04 Olin Mathieson Hair growth inhibiting by aminobenzophenones
US4161540A (en) * 1966-08-22 1979-07-17 Schering Corporation Antiandrogenic agents and methods for the treatment of androgen dependent disease states
GB1458349A (en) * 1972-12-05 1976-12-15 Sykora F Composition for and a process therewith of treating the hair and/or scalps of animals
US4039669A (en) * 1975-08-01 1977-08-02 Sterling Drug Inc. Composition for topical application and use thereof
US4139638A (en) * 1976-09-23 1979-02-13 Schering Corporation Methods for the treatment of hirsutism
FR2380775A1 (fr) * 1977-02-22 1978-09-15 Sederma Sarl Composition " apres-epilation " favorisant un ralentissement progressif de la repousse des poils
US4191775A (en) * 1977-12-15 1980-03-04 Imperial Chemical Industries Limited Amide derivatives
US4269831A (en) * 1979-05-09 1981-05-26 Sterling Drug Inc. Topical dermatological method of use of an androstenopyrazole
US4439432A (en) * 1982-03-22 1984-03-27 Peat Raymond F Treatment of progesterone deficiency and related conditions with a stable composition of progesterone and tocopherols
JP2519024B2 (ja) * 1982-06-07 1996-07-31 花王株式会社 毛髪化粧料
US4508714A (en) * 1983-11-14 1985-04-02 Tihomir Cecic Organic scalp lotion
US4885289A (en) * 1983-12-12 1989-12-05 Breuer Miklos M Alteration of character of male beard growth
US4720489A (en) * 1984-10-15 1988-01-19 Douglas Shander Hair growth modification with ornithine decarboxylase inhibitors
US4935231A (en) * 1985-08-28 1990-06-19 Repligen Corporation Use of thioredoxin, thioredoxin-derived, or thioredoxin-like dithiol peptides in hair care preparations
US5091171B2 (en) * 1986-12-23 1997-07-15 Tristrata Inc Amphoteric compositions and polymeric forms of alpha hydroxyacids and their therapeutic use
EP0309086A1 (en) * 1987-09-07 1989-03-29 Efamol Holdings Plc Treatment of male pattern baldness and of unwanted hair growth
US5096911A (en) * 1990-06-25 1992-03-17 Ahluwalia Gurpreet S Alteration of rate and character of hair growth
ATE159428T1 (de) * 1990-08-14 1997-11-15 Joseph H Handelman Enzymatische änderung des haarwuchses
US5189212A (en) * 1990-09-07 1993-02-23 University Of Georgia Research Foundation, Inc. Triarylethylene carboxylic acids with estrogenic activity
US5095007A (en) * 1990-10-24 1992-03-10 Ahluwalia Gurpreet S Alteration of rate and character of hair growth
DE4038693A1 (de) * 1990-12-05 1992-06-11 Heverhagen Ulrich Mittel zum reduzieren des wachstums bzw. zum entfernen der haare am menschlichen koerper
US5143925A (en) * 1990-12-20 1992-09-01 Douglas Shander Alteration of rate and character of hair growth
GB9118866D0 (en) * 1991-09-04 1991-10-23 Unilever Plc Cosmetic composition
GB9118979D0 (en) * 1991-09-04 1991-10-23 Unilever Plc Cosmetic composition
US5364885A (en) * 1992-11-13 1994-11-15 Ahluwalia Gurpreet S Reduction of hair growth
US5411991A (en) * 1992-12-22 1995-05-02 Shander; Douglas Method of reducing hair growth employing sulfhydryl active compounds
US5474763A (en) * 1994-03-11 1995-12-12 Shander; Douglas Reduction of hair growth
US5455234A (en) * 1994-03-16 1995-10-03 Ahluwalia; Gurpreet S. Inhibition of hair growth
GB9405076D0 (en) * 1994-03-16 1994-04-27 Inst Of Ophtalmology A medical use of matrix metalloproteinase inhibitors
US5554608A (en) * 1994-09-28 1996-09-10 Ahluwalia; Gurpreet S. Inhibition of hair growth
JP2000515511A (ja) * 1996-07-12 2000-11-21 ジヨンソン・アンド・ジヨンソン・コンシユーマー・カンパニーズ・インコーポレーテツド 毛包乳頭のアポトーシスによる毛の成長および毛の色素沈着を変える方法ならびにそのための組成物

Also Published As

Publication number Publication date
WO1999062465A1 (en) 1999-12-09
ES2205498T3 (es) 2004-05-01
ZA9711121B (en) 1998-06-23
DE69817883T2 (de) 2004-07-08
CA2333401A1 (en) 1999-12-09
AU7710498A (en) 1999-12-20
BR9815884A (pt) 2001-02-20
EP1083863A1 (en) 2001-03-21
BR9815884B1 (pt) 2009-12-01
US5962466A (en) 1999-10-05
CA2333401C (en) 2003-09-23
ATE248573T1 (de) 2003-09-15
DE69817883D1 (de) 2003-10-09
WO1998025580A1 (en) 1998-06-18
AU5520998A (en) 1998-07-03
EP1083863B1 (en) 2003-09-03

Similar Documents

Publication Publication Date Title
AR010769A1 (es) Metodo para la reduccion del crecimiento capilar en mamiferos
Young et al. Tachyphylaxis in 12-0-tetradecanoylphorbol acetate-and arachidonic acid-induced ear edema
US5928654A (en) Modulating body/cranial hair growth with lipoxygenase/cyclooxygenase inhibitors
Colonna et al. Myocardial infarction and left ventricular remodeling: results of the CEDIM trial
DK0766672T3 (da) Arylsulfonamido-substituerede hydroxamsyrer som matrixmetallopreteinase-inhibitorer
RU97112875A (ru) Модулирующая апоптоз композиция, содержащая фактор, оказывающий влияние на внутриклеточное содержание метионаля или диальдегида малоновой кислоты
Vane et al. The endothelial cell as a metabolic and endocrine organ
JPH07238037A (ja) 体毛及び／又は毛髪の成長の調節処理方法及びそれに使用する組成物
CZ225898A3 (cs) Způsob inhibice stárnutí kůže vlivem světla
CO4920241A1 (es) Compuestos inhibidores de metaloproteasas heterociclicos, composiciones farmaceuticas que los contienen y metodos para su utilizacion
CO4920240A1 (es) Compuestos inhibidores de metaloproteasa diheterociclicos, composiciones farmaceuticas que los contienen y metodos para su utilizacion
RU2013116763A (ru) Сложноэфирные пролекарства [3-(1-(1н-имидазол-4)этил)-2-метилфенил]метанола для снижения внутриглазного давления
RU2177780C2 (ru) Композиция для ухода за кожей, способ ухода за ней, способ имитации воздействия на кожу ретиноевой кислоты
RU94044456A (ru) Средство для подавления дисфункционального маточного кровотечения
UY26303A1 (es) Composiciones farmacéuticas para administración oral y tópica
AR033944A1 (es) Una composicion cosmetica anti-grasitud para el cuidado de la piel, un metodo para reducir o evitar las condiciones de piel grasa, un metodo cosmetico para reducir o evitar la secrecion de sebo de los sebocitos, un metodo para estimular la sintesis de colageno y de glicosaminoglicano con fibroblasto
Fischer et al. Effects of antihistamines on phorbol ester tumor promotion and vascular permeability changes
Warltier et al. Protection of ischemic myocardium: comparison of effects of propranolol, bevantolol and N-dimethyl propranolol on infarct size following coronary artery occlusion in anesthetized dogs
AR040378A1 (es) Formulaciones farmaceuticas de liberacion controlada
ATE450602T1 (de) Stemzelldifferenzierung induzierende promoter
AR024082A1 (es) Sales antitranspirantes y metodos para su preparacion
CA2309588A1 (en) Statin-matrix metalloproteinase inhibitor combinations
Inoki et al. Prostaglandins and leukotrienes in dental pulp: their possible roles in pulp pathophysiology
AU2003248291A1 (en) Statin-matrix metalloproteinase inhibitor combinations
CO4940413A1 (es) Nuevos metodos

Legal Events

Date Code Title Description
FB Suspension of granting procedure